. Progressive increase in human skeletal muscle AMPK␣2 activity and ACC phosphorylation during exercise. Am J Physiol Endocrinol Metab 282: E688-E694, 2002; 10.1152/ajpendo.00101.2001.-The effect of prolonged moderate-intensity exercise on human skeletal muscle AMP-activated protein kinase (AMPK)␣1 and -␣2 activity and acetyl-CoA carboxylase (ACC␤) and neuronal nitric oxide synthase (nNOS) phosphorylation was investigated. Seven active healthy individuals cycled for 30 min at a workload requiring 62.8 Ϯ 1.3% of peak O2 consumption (V O2 peak) with muscle biopsies obtained from the vastus lateralis at rest and at 5 and 30 min of exercise. AMPK␣1 activity was not altered by exercise; however, AMPK␣2 activity was significantly (P Ͻ 0.05) elevated after 5 min (ϳ2-fold), and further elevated (P Ͻ 0.05) after 30 min (ϳ3-fold) of exercise. ACC␤ phosphorylation was increased (P Ͻ 0.05) after 5 min (ϳ18-fold compared with rest) and increased (P Ͻ 0.05) further after 30 min of exercise (ϳ36-fold compared with rest). Increases in AMPK␣2 activity were significantly correlated with both increases in ACC␤ phosphorylation and reductions in muscle glycogen content. Fat oxidation tended (P ϭ 0.058) to increase progressively during exercise. Muscle creatine phosphate was lower (P Ͻ 0.05), and muscle creatine, calculated free AMP, and free AMP-to-ATP ratio were higher (P Ͻ 0.05) at both 5 and 30 min of exercise compared with those at rest. At 30 min of exercise, the values of these metabolites were not significantly different from those at 5 min of exercise. Phosphorylation of nNOS was variable, and despite the mean doubling with exercise, statistically significance was not achieved (P ϭ 0.304). Western blots indicated that AMPK␣2 was associated with both nNOS and ACC␤ consistent with them both being substrates of AMPK␣2 in vivo. In conclusion, AMPK␣2 activity and ACC␤ phosphorylation increase progressively during moderate exercise at ϳ60% of V O2 peak in humans, with these responses more closely coupled to muscle glycogen content than muscle AMP/ ATP ratio. adenosine monophosphate-activated protein kinase; acetylcoenzyme A carboxylase-␤; neuronal nitric oxide synthase; prolonged exercise; humans AMP-ACTIVATED PROTEIN KINASE (AMPK) plays an important role in coordinating metabolism with a number of physiological processes (16, 22) . In rat skeletal muscle, activation of AMPK appears to lead to enhanced fat oxidation and glucose uptake (3, 19, 25) . In transgenic mice expressing a dominant negative mutant of AMPK, there is impaired glucose uptake in response to both contraction and hypoxia (26). There are two isoforms of AMPK, AMPK␣1 and -␣2, expressed in skeletal muscle. Maximal sprint exercise [ϳ200% peak O 2 consumption (V O 2 peak )] over 30 s in humans causes a large increase in the calculated free AMP and free AMP-to-ATP ratio (AMP/ATP) (28) and activates both AMPK␣1 and -␣2 (6). AMPK␣1 is not activated during lower intensity exercise such as at 50 or 70% V O 2 peak , or after 5 min of exercise at 90% V O 2 peak after 55 min of cycling at 75% V O 2 peak (75-90% V O 2 peak ) (14, 39). AMPK␣2 activity is increased after exercise at 70 and 75-90% V O 2 peak , but not after exercise at 50% V O 2 peak (14, 39). There are smaller increases in free AMP and the free AMP/ATP ratio during low-intensity submaximal exercise that may be insufficient to activate AMPK (21, 28). During exercise at ϳ60% V O 2 peak , the level of muscle energy imbalance increases (21), and glucose uptake (4) and fat oxidation (12) increase from rest. If AMPK␣2 activity is important for activation of fat oxidation and glucose uptake, one would expect increases in AMPK␣2 activity and phosphorylation of acetyl-CoA carboxylase (ACC␤) at this moderate exercise intensity.
activation of AMPK appears to lead to enhanced fat oxidation and glucose uptake (3, 19, 25) . In transgenic mice expressing a dominant negative mutant of AMPK, there is impaired glucose uptake in response to both contraction and hypoxia (26) . There are two isoforms of AMPK, AMPK␣1 and -␣2, expressed in skeletal muscle. Maximal sprint exercise [ϳ200% peak O 2 consumption (V O 2 peak )] over 30 s in humans causes a large increase in the calculated free AMP and free AMP-to-ATP ratio (AMP/ATP) (28) and activates both AMPK␣1 and -␣2 (6). AMPK␣1 is not activated during lower intensity exercise such as at 50 or 70% V O 2 peak , or after 5 min of exercise at 90% V O 2 peak after 55 min of cycling at 75% V O 2 peak (75-90% V O 2 peak ) (14, 39) . AMPK␣2 activity is increased after exercise at 70 and 75-90% V O 2 peak , but not after exercise at 50% V O 2 peak (14, 39) . There are smaller increases in free AMP and the free AMP/ATP ratio during low-intensity submaximal exercise that may be insufficient to activate AMPK (21, 28) . During exercise at ϳ60% V O 2 peak , the level of muscle energy imbalance increases (21) , and glucose uptake (4) and fat oxidation (12) increase from rest. If AMPK␣2 activity is important for activation of fat oxidation and glucose uptake, one would expect increases in AMPK␣2 activity and phosphorylation of acetyl-CoA carboxylase (ACC␤) at this moderate exercise intensity.
Skeletal muscle fat oxidation is dependent on fatty acids being transported into the mitochondria via carnitine palmitoyltransferase I (CPT I) (32) . Fatty acid transport via CPT I is allosterically inhibited by malonyl-CoA (32) . It has been shown in rat skeletal muscle that AMPK phosphorylates and inhibits ACC␤ (36) , which is responsible for converting acetyl-CoA to malonyl-CoA. Indeed, treadmill exercise in rats causes an increase in AMPK activity and reductions in ACC␤ activity and malonyl-CoA content (37) . In addition, activation of AMPK via 5Ј-aminoimidazole-4-carboxyamide-1-␤-D-ribofuranoside (AICAR) causes decreases in ACC␤ activity and malonyl-CoA levels as well as an increase in fat oxidation in perfused rat hindlimb (25) . In humans, malonyl-CoA decreases (12-17%) signifi-cantly during exercise at intensities between 85 and 100% V O 2 peak (8, 27) , but not during exercise at 60-65% V O 2 peak (8, 27) . However, Dean et al. (8) found decreased ACC␤ activity at 60% V O 2 peak as well as at the higher exercise intensities despite no change in malonyl-CoA at 60% V O 2 peak . Because ACC␤ activity is reduced at 60% V O 2 peak , it is likely that ACC␤ phosphorylation by AMPK is increased at this intensity. We found that ACC␤ phosphorylation by AMPK increases 8.5-fold during sprint exercise in humans (6) . Therefore, the first aim of this study was to determine whether prolonged exercise at ϳ60% V O 2 peak increased AMPK␣2 activity and ACC␤ phosphorylation in human skeletal muscle.
Activation of AMPK in rat skeletal muscle by AICAR has been shown to increase skeletal muscle glucose uptake (19) by increasing the translocation of GLUT-4 to the sarcolemma (23) . AICAR appears to act via an insulin-independent mechanism that is believed to be similar to contraction-stimulated glucose uptake (19) . Hayashi et al. (19) have shown that the combination of AICAR and contraction is not additive on glucose uptake, whereas both contraction with insulin and AICAR with insulin have additive effects on glucose uptake. Exercise-stimulated glucose uptake appears to involve both AMPK-dependent and AMPK-independent mechanisms (26) . The mechanism by which AMPK increases GLUT-4 translocation and glucose uptake is unknown. Previously we found infusion of a nitric oxide synthase (NOS) inhibitor during cycling in humans reduces leg glucose uptake without affecting leg blood flow (4) . Furthermore, we recently found an eightfold increase in neuronal NOS (nNOS) phosphorylation by AMPK immediately after 30-s maximal sprint exercise in humans (6) . Although there is evidence that NO (produced by nNOS) is a signaling intermediate in stimulation of GLUT-4 translocation (31) and glucose uptake during rat skeletal muscle contraction (2), other studies do not support a role for NO in contraction-stimulated glucose transport (11, 20) .
Glucose uptake and fat oxidation increase from 5 to 30 min of exercise in humans (12) , but a study in rats found that there was no change in AMPK activity and ACC␤ activity from 5 to 30 min of treadmill running (37) . It is therefore important to determine whether AMPK␣2 activity, ACC␤ phosphorylation, and nNOS phosphorylation increase progressively during prolonged moderate exercise in humans and whether AMPK is associated with these enzymes in human skeletal muscle.
METHODS
Subjects. Seven active, healthy individuals (3 males and 4 females) volunteered for this study, which was approved by the Monash University Standing Committee on Ethics in Research involving Humans, in accordance with National Health and Medical Research Council of Australia guidelines. Before commencing the study, they completed a medical questionnaire and provided informed, written consent. Their mean age, weight, and height were 20 Ϯ 1 yr, 67.2 Ϯ 4.5 kg, and 168.3 Ϯ 4.8 cm, respectively (means Ϯ SE). None of the females was using oral contraceptives.
Experimental procedures. Peak pulmonary oxygen consumption during cycling (V O2 peak) was determined using a graded exercise test to volitional exhaustion on an electrically braked cycle ergometer (Lode, Gronignen, The Netherlands) and averaged 2.4 Ϯ 0.2 l/min (35.9 Ϯ 2.3 ml ⅐ kg Ϫ1 ⅐ min Ϫ1 ). On a separate day, subjects completed a familiarization trial, which involved cycling continuously for 30 min at a workload calculated from the V O2 peak test to be equivalent to 60% of their V O2 peak. Approximately 10 days later, subjects returned to the laboratory having abstained for the previous 24 h from alcohol, caffeine, and strenuous exercise and from food overnight. The experimental trial consisted of 30 min of cycling at 62.8 Ϯ 1.3% of V O2 peak (98 Ϯ 11 W) with muscle biopsies conducted at rest and after 5 and 30 min of exercise. Muscle biopsies were obtained from three separate sites of the vastus lateralis muscle under local anesthetic by use of the percutaneous needle biopsy technique, with suction. Once removed, muscle samples were frozen in liquid nitrogen. Muscle samples obtained at rest were frozen in liquid nitrogen 7 Ϯ 1 s after the biopsying of the muscle. The muscle samples obtained at 5 and 30 min of exercise were frozen in liquid nitrogen 17 Ϯ 2 s after the cessation of exercise. AMPK␣1 and -␣2 activity, ACC␤ phosphorylation, nNOS phosphorylation, and muscle metabolites were later analyzed in the muscle samples. Expired air was collected into Douglas bags for 3 min after 7, 17, and 27 min of exercise for calculation of oxygen consumption, carbon dioxide production, respiratory exchange ratio, fat oxidation, and carbohydrate oxidation. Heart rate was noted at 10, 20, and 30 min of exercise.
Analytical techniques. Oxygen and carbon dioxide content in the expired air was analyzed using Exerstress OX21 and CO21 electronic analyzers (Clinical Engineering Solutions, Sydney, Australia) calibrated with gases of known composition. Gas volume was measured using a dry gas meter (American Meter, Vacumed, Ventura, CA) calibrated against a Tissot spirometer.
Approximately 20 mg of each muscle sample were freezedried for analysis of muscle metabolites. Each sample was crushed to a fine powder, with any visible connective tissue being removed. Muscle glycogen was extracted from ϳ1 mg of freeze-dried muscle by incubating the sample in HCl for 2 h at 100°C, and after neutralization with NaOH, the sample was analyzed for glucose units with the use of an enzymatic fluorometric method (29) . Muscle metabolites [ATP, creatine phosphate (PCr), creatine (Cr), and lactate] were extracted from ϳ2 mg of freeze-dried muscle by use of the procedure of Harris et al. (17) and analyzed using enzymatic fluorometric techniques (24) . The contents of ATP, PCr, and Cr were corrected to the peak total Cr (PCr ϩ Cr) content for each subject to account for any nonmuscle contamination of the muscle samples. Free ADP and AMP were calculated as outlined previously (6) .
Approximately 80 mg of wet muscle was homogenized in buffer A (50 mM Tris ⅐ HCl, pH 7.5, 1 mM EDTA, 1 mM EGTA, 1 mM dithiothreitol, 50 mM NaF, 5 mM Na pyrophosphate, 10% glycerol, 1% Triton X-100, 10 g/ml trypsin inhibitor, 2 g/ml aprotinin, 1 mM benzamidine, 1 mM phenylmethylsulfonyl fluoride). The homogenates were incubated with the AMPK␣1 or AMPK␣2 antibody-bound protein A beads for 2 h at 4°C. Immunocomplexes were washed with PBS and suspended in 50 mM Tris (pH 7.5) buffer for AMPK activity assay (7) . The polyclonal antipeptide antibodies to AMPK␣1 and -␣2 were raised to nonconserved regions of the AMPK isoforms -␣1 (373-390, CARHTLDELNPQKSKHQG) and ␣2 (490-516, CSAAGLHRPRSSVDSSTAENHSLSG). There is no cross-reactivity between the polyclonal antibodies (5). The AMPK activities in the immune complexes were measured in either the presence or absence of 150 M AMP. Activities were calculated as picomoles of phosphate incorporated into the ACC␤(73-87)A 77 peptide per minute per milligram of total protein subjected to immunoprecipitate. Muscle homogenates were also incubated either with immobilized monomeric avidin agarose beads or with 2Ј,5Ј-ADP Sepharose beads to affinity purify ACC␤ and nNOS, respectively. Avidin affinity purification of ACC has been used extensively (8, 35) , as has 2Ј,5Ј-ADP-Sepharose for nNOS isolation (15) . Partially purified AMPK␣2 does not bind to either immobilized monomeric avidin agarose beads or 2Ј,5Ј-ADP Sepharose beads (results not shown), and the other biotincontaining enzymes pyruvate carboxylase, methylcrotonyl carboxylase, and proprionyl carboxylase are not known to be substrates for the AMPK. The ACC␤ fraction was subjected to SDS-PAGE, and ACC␤ was detected by immunoblotting with either anti-phospho-ACC␤-79 polyclonal antibody (6) or horseradish peroxidase-conjugated streptavidin (DAKO, Carpinteria, CA) for total ACC␤. The nNOS fraction was subjected to SDS-PAGE, and nNOS was detected by immunoblotting with either antiphospho-nNOS-1451 polyclonal antibody (6) or human nNOS antibody (N-31020; Transduction Laboratory, Lexington, KY). In an attempt to determine whether ACC␤ and nNOS are associated with AMPK␣2 in vivo in humans, the immunoblots for ACC␤ and nNOS were stripped and then reimmunoblotted with the AMPK␣2-specific antibody (7) .
Statistical analysis. Results were analyzed using one-way or two-way repeated-measures analysis of variance utilizing the statistical package SPSS. Specific differences were located using the least significant difference (LSD) test. A significance level of P Ͻ 0.05 was set.
RESULTS
Muscle ATP concentration at 5 min of exercise was not significantly different from the value at rest, whereas muscle PCr concentration was lower (P Ͻ 0.05), and muscle Cr concentration was higher (P Ͻ 0.05), at 5 min of exercise compared with those at rest ( Table 1 ). In addition, calculated free ADP, calculated free AMP, and the calculated free AMP/ATP ratio were higher (P Ͻ 0.05) at 5 min of exercise than at rest (Table 1 ). There was no significant difference in the values of these muscle metabolites at 5 min compared with 30 min of exercise. Muscle glycogen concentration tended to decrease progressively during exercise, with the concentration at 30 min being significantly (P Ͻ 0.05) less than both the concentration at rest and that at 5 min of exercise (Table 1) . Muscle lactate concentration tended to increase during exercise (P ϭ 0.097; Table 1 ). AMPK␣1 activity measured without added AMP did not change during exercise (Fig. 1A) . In contrast, AMPK␣2 activity measured without added AMP increased after 5 min (ϳ2-fold) of exercise and then increased further after 30 min (ϳ3-fold) of exercise (P Ͻ 0.05; Fig. 1B) . Addition of 150 M AMP increased (P Ͻ 0.05) AMPK␣1 and -␣2 activity to a similar extent in the rest and exercised muscle samples, and the responses of the AMPK␣1 and -␣2 isoforms to AMP were similar (Fig. 1) . ACC␤ phosphorylation increased greatly and progressively with exercise, being ϳ18-fold greater than rest at 5 min (P Ͻ 0.05) and 36-fold greater than rest at 30 min of exercise (P Ͻ 0.05; Fig.  2 ). There was a significant correlation across the trial between AMPK␣2 activity and ACC␤ phosphorylation (r ϭ 0.805, P Ͻ 0.001 without AMP; r ϭ 0.637, P ϭ 0.004 with AMP). There was also a significant negative correlation across the trial between AMPK␣2 activity Values are mean muscle metabolite concentrations (ϮSE) before and during exercise at 63.0 Ϯ 1.4% peak O2 consumption expressed as mmol/kg dry muscle, (n ϭ 6), except for free ADP and free AMP, which are in mol/kg dry muscle. Cr, creatine; PCr, creatine phosphate. * Different from rest (P Ͻ 0.05); † different from 5 min of exercise (P Ͻ 0.05). Fig. 1 . AMP-activated protein kinase (AMPK)␣1 activity (A) and AMPK␣2 activity (B) before and during exercise at 62.8 Ϯ 1.3% of peak O2 consumption (V O2 peak; n ϭ 7). The AMPK activity in the immune complex was measured in either the presence or absence of AMP (150 M). *Different from rest (P Ͻ 0.05); and † different from 5 min of exercise (P Ͻ 0.05).
and muscle glycogen (r ϭ Ϫ0.574, P ϭ 0.01 without AMP; r ϭ Ϫ0.533, P ϭ 0.02 with AMP). Although the level of nNOS phosphorylation approximately doubled with exercise, this was not a statistically significant increase (P ϭ 0.304; Fig. 3 ). Previously, we found that more intense sprint exercise was associated with a 5.5-fold increase in nNOS phosphorylation at Ser 1451 (6) . It was of interest to test whether nNOS is associated with AMPK␣2 in vivo. We detected AMPK␣2 associated with 2Ј,5Ј-ADP-Sepharose affinity-purified nNOS in immunoblots (Fig. 4) . This indicated that nNOS is associated with AMPK␣2 in vivo, supporting the idea that it is a direct substrate. Partially purified AMPK␣2 does not bind 2Ј,5Ј-ADP-Sepharose beads. Similarly, we found that AMPK␣2 was associated with avidin affinity-purified ACC␤ (Fig. 4) , indicating that ACC␤ is a direct substrate of AMPK␣2 in vivo. AMPK␣2 is not bound by immobilized monomeric avidin agarose beads. The amount of AMPK␣2 associated with either ACC␤ or nNOS was the same for rest and exercise samples (Fig. 4) . Oxygen consumption and heart rate over the 30-min cycling period averaged 1.52 Ϯ 0.08 l/min and 147 Ϯ 3 beats/min, respectively. The respiratory exchange ratio decreased (P Ͻ 0.05) significantly during the trial, averaging 0.97 Ϯ 0.03, 0.95 Ϯ 0.03, and 0.94 Ϯ 0.03, at 10, 20, and 30 min of exercise, respectively. Calculated fat oxidation tended (P ϭ 0.058) to increase during exercise, and calculated carbohydrate oxidation tended (P ϭ 0.123) to decrease during exercise (Fig. 5) .
DISCUSSION
The major finding of this study was that there is a large, progressive increase in ACC␤ phosphorylation during moderate-intensity exercise at ϳ60% V O 2 peak in humans, which is coupled with the progressive increase in AMPK␣2 activity and fat oxidation. We found that the progressive increase in AMPK␣2 activity during exercise was more closely coupled to changes in muscle glycogen content during exercise than changes in muscle energy balance, since muscle glycogen content was the only metabolic parameter measured whose change between 5 and 30 min was statistically significant. These results indicate that changes in AMPK activity may occur independently of detectable increases in the AMP/ATP ratio. Enhanced activation of skeletal muscle AMPK is seen with reduced muscle glycogen content in both contracting rat muscle (10) and during exercise in humans (30) . We interpret our results as indicating that the initial increase in AMPK activity from rest depends on the AMP/ATP ratio but that the subsequent increase between 5 and 30 min is dependent on the reduction in muscle glycogen content.
Maximal sprint exercise (ϳ200% V O 2 peak ) in humans results in an increase in the activity of both skeletal muscle AMPK␣1 and -␣2 (6). However, in several studies, including this study (Fig. 1A) , AMPK␣1 activity does not increase during submaximal exercise in humans (14, 39) . It has now been shown during exercise in humans that AMPK␣1 activity is not increased above the resting levels at 50 (14) , ϳ60 (Fig. 1A) , 70 (14) , and 75-90% (39) V O 2 peak . This suggests that AMPK␣1 activation may not be required during pro- longed exercise and is not responsible for the increase in ACC␤ phosphorylation in the present study (Fig. 2) . Two previous studies in humans have found no increase in AMPK␣2 activity during exercise at 50% V O 2 peak but an increase at 70 (14) , or 75-90% (39) of V O 2 peak . Our results indicate that there is a threshold for activation of AMPK␣2 that occurs at ϳ60% V O 2 max within the moderate exercise range.
Hypoxia is a very strong stimulator of AMPK (18), and it is possible that a level of hypoxia is required before AMPK␣1 is activated in skeletal muscle. As discussed earlier, we found that both AMPK␣1 and -␣2 were increased after sprint cycling in humans (6) . Such exercise is likely to be associated with a large decrease in intramuscular PO 2 . Intense electrical stimulation of rat skeletal muscle in vitro also increases both AMPK␣1 and -␣2 (18) , and it has been suggested that a level of hypoxia exists under such conditions (39) . In isolated rat muscle, hypoxia causes much greater increases in both AMPK␣1 and -␣2 than does either in vitro electrical stimulation or exposure to AICAR (18) . In situ stimulation of rat muscle, where the circulation is still intact, only activates AMPK␣2 (36) .
Skeletal muscle ACC␤ phosphorylation by AMPK increased progressively during exercise (Fig. 2) , in line with the progressive increase in AMPK␣2 activity (Fig.  1B ) and fat oxidation (Fig. 5) . Our results differ from those obtained in rat muscle, where it was found that there was no change in AMPK activity and ACC activity from 5 to 30 min of treadmill running (37) . The reason for this discrepancy is unclear but may reflect species differences. We have found that AMPK␣2 and ACC␤ are associated in human skeletal muscle in vivo (Fig. 4) , consistent with ACC␤ being a direct substrate for AMPK. Previously, we found that ACC␤ phosphorylation increased ϳ8.5-fold after a maximal 30-s sprint (6) . There is a greater degree of increase in ACC␤ phosphorylation (18-fold) during moderate-exercise intensity; however, this was measured at 5 min (Fig. 2) , providing a 10-fold increase in exercise duration to allow for the accumulation of more phosphorylated ACC␤ compared with the sprint exercise study (6) .
In line with the progressive elevation in ACC␤ phosphorylation during exercise, we found a trend (P ϭ 0.058) for fat oxidation to increase progressively during the exercise bout. Although it is well documented that skeletal muscle malonyl-CoA decreases during exercise in rats (37) , the findings in humans are less clear. Two groups have shown that skeletal muscle malonyl-CoA levels are not reduced during exercise at 60-65% V O 2 peak , but there is a small (12-17%) reduction during exercise at 85-100% V O 2 peak (8, 27) . The smaller change in measured malonyl-CoA during exercise in humans than in rats has been suggested to be due to the much lower levels in human skeletal muscle, there- fore making it difficult to detect small changes (32) . It has therefore been suggested that measurement of AMPK activity and ACC␤ activity in humans is an alternative to measuring malonyl-CoA, because reductions in ACC␤ activity lead to reductions in malonylCoA (32) . Phosphorylation of ACC␤ at the serine 79 AMPK-specific site has been shown to be a potent inhibitor of ACC␤ activity in rat skeletal muscle (36, 38) . Indeed, Dean et al. (8) found decreased ACC␤ activity compared with rest after exercise at 60% V O 2 peak in humans, but there was no detectable change in malonyl-CoA. It seems reasonable that the progressive increase in fat oxidation (P Ͻ 0.058) observed during exercise in the present study reflects the progressive increase in ACC␤ phosphorylation. The possibility that AMPK may have a dual role in regulating malonyl-CoA has been raised by the report that AMPK phosphorylates and activates malonyl-CoA decarboxylase (33) . It should also be noted that there is some evidence that factors other than malonyl-CoA, such as muscle pH (34) and muscle carnitine levels, influence fat oxidation in skeletal muscle during exercise.
Glucose uptake increases progressively during prolonged submaximal exercise (12) . If AMPK activity is indeed playing a role in glucose uptake during exercise, one would expect that it would also increase progressively with exercise duration. This was found to be the case with regard to AMPK␣2 activity, which increased progressively, whereas AMPK␣1 activity did not change during exercise (Fig. 1) . The downstream substrate(s) of AMPK responsible for activating glucose uptake is not known. We (4) and others (1) have found that NOS inhibition reduces skeletal muscle glucose uptake in response to exercise. Fryer et al. (13) found that AICAR increased both NOS activity and glucose uptake in rat soleus and extensor digitorum longus skeletal muscle strips and that both of these effects of AICAR were abolished with a NOS inhibitor. However, other studies do not support the concept that NO is directly involved in the signaling pathway for contraction-stimulated glucose uptake (11, 20) . Dean et al. (8) recently reported that NOS inhibition has little effect on AICAR-or hypoxia-stimulated glucose transport in rat skeletal muscle (9) . The reason for these differing results is unclear. Because AMPK stimulates glucose uptake into skeletal muscle (3, 19) and AMPK has been shown to phosphorylate nNOS during intense sprint exercise (6), we tested whether nNOS phosphorylation increases during moderate-intensity exercise. Although we found that nNOS phosphorylation, on average, doubled during exercise (Fig. 3) , this was not statistically significant and was much smaller than the 5.5-fold increase we observed after a maximal 30-s sprint (6) . In addition, the increase in nNOS phosphorylation was much less than the level of phosphorylation of ACC␤ (36-fold) during exercise in the present study. Nevertheless, we find that nNOS is associated with AMPK␣2, supporting the view that nNOS is a direct substrate for AMPK␣2 in vivo (Fig. 4) . At this stage, it is not clear what the physiological function of nNOS phosphorylation at Ser 1451 is in exercising skeletal muscle. In view of the modest phosphorylation during moderate exercise and the conflicting results regarding the role of NO in glucose transport, it would seem unlikely that Ser 1451 phosphorylation is essential for exercise-induced glucose transport.
In conclusion, skeletal muscle AMPK␣2, but not AMPK␣1, activity increased progressively during 30 min of moderate-intensity exercise at ϳ60%VO 2 peak . There was also a large, progressive increase in ACC␤ phosphorylation during exercise, and the increase in AMPK␣2 activity correlated with the increase in ACC␤ phosphorylation. Fat oxidation also tended to increase progressively during exercise. After the first 5 min of exercise, the increases in AMPK␣2 activity and ACC␤ phosphorylation were more closely related to changes in muscle glycogen content than muscle AMP/ATP levels.
